Gallacher Capital Management LLC Gilead Sciences, Inc. Transaction History

Gallacher Capital Management LLC

  • $190 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
BUY
$73.27 - $83.09 $90,634 - $102,782
1,237 Added 28.45%
5,585 $452 Million
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $103,959 - $113,422
1,406 Added 47.79%
4,348 $326 Million
Q2 2023

Aug 11, 2023
BUY
$76.01 - $86.7 $223,621 - $255,071
2,942 New
2,942 $227 Million

Others Institutions Holding GILD

# of Institutions
1,893
Shares Held
1.02B
Call Options Held
12M
Put Options Held
9.04M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Gallacher Capital Management LLC Portfolio

Follow Gallacher Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gallacher Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gallacher Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email